A61P 33 - Antiparasitic agents

Patents for A61P 33 - Antiparasitic agents (21,787)
10/2002
10/25/2002	CA2382806A1 Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs
10/24/2002	WO2002083873A2 Enzymes
10/24/2002	WO2002083724A1 Antigens for raising an immune response against rickettsieae and ehrlichieae pathogens
10/24/2002	WO2002083709A2 Kinases and phosphatases
10/24/2002	WO2002083644A1 Halogenated quinoline derivatives and ectoparasite controllers
10/24/2002	WO2002083641A2 Amino-aza-cyclohexanes for the treatment of malaria
10/24/2002	WO2002083629A1 Bissulfonamide derivatives as inhibitors of dehydroquinate synthetases and type ii dehydroquinases
10/24/2002	WO2002083627A2 Ligands des integrins avss6
10/24/2002	WO2002083152A1 Activation of natural killer cells by adenosine a3 receptor agonists
10/24/2002	WO2002083063A2 Method of improving systemic exposure of subcutaneously administered therapeutic proteins
10/24/2002	WO2002040038A3 M. tuberculosis chaperonin 10 and uses thereof
10/24/2002	US20020156264 And method of using the carboxypeptidase polypeptides and polynucleotides as a target for diagnosis and treatment in carboxypeptidase-related disorders
10/24/2002	US20020156102 Piperidine amides as modulators of chemo kine receptor activity
10/24/2002	US20020156081 Pyrazolopyrimidines as therapeutic agents
10/24/2002	US20020156030 Heterocyclic aromatic compounds and uses thereof
10/24/2002	US20020156027 Ketolide antibiotics
10/24/2002	US20020155609 Monocyte-specific particulate delivery vehicle
10/24/2002	US20020155562 Glutathionylspermidine synthetase and processes for recovery and use thereof
10/24/2002	US20020155441 Polypeptides for use in the, detection, prevention, treatment and diagnosis of malarial infection
10/24/2002	US20020155127 Genetic vaccine against human immunodeficiency virus
10/24/2002	US20020155115 Cancer therapy
10/24/2002	DE10119423A1 New cyanoimino- or nitroimino-substituted azole derivatives or analogs, useful as pesticides, e.g. insecticides, acaricides, nematocides, ectoparasiticides or antifouling agents
10/24/2002	CA2444247A1 Inhibitors of integrin .alpha.v.beta.6
10/24/2002	CA2443408A1 Kinases and phosphatases
10/24/2002	CA2443244A1 Enzymes
10/23/2002	EP1251125A2 New camptothecin analogues, preparation methods thereof, use thereof as drugs, and pharmaceutical compositions containing them
10/23/2002	EP1250343A1 Azalide antibiotic compositions
10/23/2002	EP1250142A1 Multivalent electron active compositions and methods of making and using same
10/23/2002	CN1376160A Novel macrolide antibiotics
10/23/2002	CN1375293A Mixed vermifuge injection containing iodo-ether salicylamine
10/23/2002	CN1375291A Veterinary mixed injection containing levamisole or its salts
10/22/2002	US6469067 For treatment of livestock for parasites; comprises 1-(4-chloro-3-(3-chloro-5-trifluoromethyl-2-pyridyloxy) phenyl)-3-(2,6-difluorobenzoyl)urea and one of: ivermectin, doramectin, moxidectin and selamectin
10/22/2002	US6469045 Thalidomide and various related compounds such as thalidomide precursors, analogs, metabolites and hydrolysis products; oral administration
10/22/2002	US6469018 Compounds
10/22/2002	US6468966 Octacyclodepsipeptides having an endoparasiticidal action
10/22/2002	US6468756 Methods of identifying compounds that bind to SNORF25 receptors
10/22/2002	US6468526 For therapy of vaginal and gastrointestinal infections
10/17/2002	WO2002081728A2 Quinoline inhibitors of hyak1 and hyak3 kinases
10/17/2002	WO2002080979A2 Conjugate of hydroxyalkyl starch and an active agent
10/17/2002	WO2002080926A1 Pyrazolopyrimidines as therapeutic agents
10/17/2002	WO2002080923A1 Substances for use in therapy of diseases that are caused by highly proliferative cells
10/17/2002	WO2002080895A2 Treatment of malaria with farsenyl protein transferase inhibitors
10/17/2002	WO2002080851A2 Chimeric vaccines
10/17/2002	WO2002080840A2 Immunity adjuvant containing a complexed metal cation and vaccine containing same
10/17/2002	WO2002029061A3 G-protein coupled receptors
10/17/2002	WO2002008420A3 A method of down-regulating gene expression
10/17/2002	WO2001098323A3 G-protein coupled receptors
10/17/2002	WO2001049279A3 Use of steroidal alkaloids to reverse multidrug resistance
10/17/2002	WO2001040497A3 Method for obtaining nucleic acids from an environment sample
10/17/2002	US20020151677 Replikins and methods of identifying replikin-containing sequences
10/17/2002	US20020151577 Antiparasitic composition for the treatment and protection of pets
10/17/2002	US20020151049 Self-enhancing, pharmacologically controllable expression systems
10/17/2002	US20020150636 Anti-leishmanial activity of betel leaf extract
10/17/2002	DE10118550A1 New 3-ethanoylamino-3-phenyl-propionic acid derivatives, are integrin agonists or antagonists useful e.g. for treating angiogenic, cardiovascular, inflammatory, osteolytic or tumor diseases or infections
10/17/2002	CA2446462A1 Chimeric vaccines
10/17/2002	CA2441442A1 Conjugate of hydroxyalkyl starch and an active agent
10/17/2002	CA2440724A1 Pyrazolopyrimidines as therapeutic agents
10/16/2002	EP1248842A1 2871 receptor, a g-protein coupled receptor and methods of use thereof
10/16/2002	EP1248836A2 Hybrid cells obtainable from antigen presenting cells
10/16/2002	EP1248801A1 Human polynucleotides, polypeptides, and antibodies
10/16/2002	EP1248785A1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same
10/16/2002	EP1248646A2 Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another enteric pathogen
10/16/2002	EP1248624A1 3,4-DIHYDRO-(1H)-QUINAZOLIN-2-ONES AND THEIR USE AS CSBP/p38 KINASE INHIBITORS
10/16/2002	EP1248612A1 Novel compounds and compositions as protease inhibitors
10/16/2002	EP0975632B1 Alkaloid halide salts of swainsonine and methods of use
10/16/2002	EP0639225B1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology
10/16/2002	CN1374960A Novel integrain receptor antagonists
10/15/2002	US6465437 Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
10/15/2002	US6464971 Anionic or cationic dendrimer antimicrobial or autiprotozoan compositions
10/10/2002	WO2002079517A1 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor
10/10/2002	WO2002079448A2 G-protein coupled receptors
10/10/2002	WO2002079441A2 Secreted proteins
10/10/2002	WO2002079146A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002	WO2002078733A1 Monocyte-specific particulate delivery vehicle
10/10/2002	WO2002078718A2 Compositions, methods and apparatuses for singlet oxygen delivery
10/10/2002	WO2002078698A2 Polarisation of dendritic cells (treatment of infections, cancer and autoimmune diseases) using histamine
10/10/2002	WO2002078622A2 Targeted oxidative therapeutic formulation
10/10/2002	WO2002078603A2 Plasmodium falciparum erythrocyte binding protein baebl for use as a vaccine
10/10/2002	WO2002004612A3 Drug metabolizing enzymes
10/10/2002	WO2001098353A3 Secreted proteins
10/10/2002	WO2001077174A3 Human transporters and ion channels
10/10/2002	WO2001074382A9 Method of treatment using ligand-immunogen conjugates
10/10/2002	WO2001072728A9 Novel piperazine derivatives
10/10/2002	US20020147235 Storage stable microbiocides
10/10/2002	US20020147192 Viricides; antiinflammatory agents; antiallergens; antiarthritic agents
10/10/2002	US20020147188 Protease inhibitors
10/10/2002	US20020146843 Controlling protein levels in eucaryotic organisms
10/10/2002	US20020146436 For protection of bovines and canines from abortion caused by Neospora caninum
10/10/2002	US20020146435 In ovo vaccination against coccidiosis
10/10/2002	DE10117676A1 Pesticidal composition, useful for controlling fleas and ticks on animals, contains permethrin and imidacloprid, in N-methylpyrrolidone
10/10/2002	CA2455915A1 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor
10/10/2002	CA2442064A1 G-protein coupled receptors
10/10/2002	CA2442062A1 Secreted proteins
10/10/2002	CA2438272A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002	CA2435390A1 Compositions, methods and apparatuses for singlet oxygen delivery
10/09/2002	EP1246935A2 Highly conserved genes and their use to generate probes and primers for detection of microorganisms
10/09/2002	EP1246842A1 Nk cell receptor polynucleotides, polypeptides, and antibodies
10/09/2002	EP1246840A2 Human and parasite orphan receptor proteins
10/09/2002	EP1246630A1 Compositions and methods for facilitating skin growth and managing skin conditions
10/09/2002	EP1246629A1 Methods of using electron active compounds for managing cancer

1 ... 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 ... 218